register

News & Trends - MedTech & Diagnostics

Prostheses List reforms and sustainability of private healthcare high on medtech sector agenda ahead of Federal Budget

Health Industry Hub | February 8, 2023 |

MedTech News: The Medical Technology Association of Australia (MTAA) has raised several issues impacting the medtech sector and the broader care for patients in its pre-Budget submission.

Ian Burgess, CEO of MTAA joined Health industry Hub to discuss concerns relating to the current cost recovery funding model for the TGA, the anticipated impact on the medtech sector and the availability of innovative technologies for Australian patients.

Mr Burgess reflected on the Prostheses List (PL) reforms which have been complex and challenging, involving a diverse range of stakeholders. Fifty-one per cent (51%) of medical devices on the PL had a benefit reduction on 1 July 2022, with further reductions to follow on 1 March and 1 July 2023. Savings of over $80m will be delivered in 2022-23. The MTAA pre-budget submission points to several issues relating to the PL reforms.

As we face significant challenges across the broader healthcare ecosystem impacting patient care, Mr Burgess acknowledged the evolution in the digital health sector since 2020 and the potential impact of enhancing care. However, local regulation and reimbursement frameworks remain a key barrier to broader reimbursement of digital health applications for use in the community and uptake by clinicians and consumers. Mr Burgess discussed the impact on the medtech sector and MTAA’s recommendations to government on this matter.

A reform agenda “with a whole government approach” is critical to drive a sustainable health sector. Mr Burgess said the MTAA is urging the government to implement several measures, including a Private Health System Authority, to oversee private health insurance “to increase sustainability, improve the value proposition and to protect patients.”

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - Pharmaceuticals

Medicines Australia and AusBiotech CEOs set agenda for the new year

Medicines Australia and AusBiotech CEOs set agenda for the new year

Health Industry Hub | January 16, 2025 |

Liz de Somer, CEO of Medicines Australia, and Bek Cassidy, CEO of AusBiotech, look back on the key accomplishments of […]

More


News & Trends - MedTech & Diagnostics

MTAA and PTA CEOs voice outlook for the year ahead

MTAA and PTA CEOs voice outlook for the year ahead

Health Industry Hub | January 16, 2025 |

Ian Burgess, CEO of the Medical Technology Association of Australia (MTAA), and Dean Whiting, CEO of Pathology Technology Australia (PTA), […]

More


ESG

Boehringer Ingelheim sets sustainability benchmark in NZ

Boehringer Ingelheim sets sustainability benchmark in NZ

Health Industry Hub | January 16, 2025 |

Boehringer Ingelheim’s Auckland office has achieved a milestone in sustainability, earning the prestigious 6 Green Star Interiors certification from the […]

More


News & Trends - Pharmaceuticals

Scathing report exposes Labor’s mismanagement of the PBS

Scathing report exposes Labor’s mismanagement of the PBS

Health Industry Hub | January 16, 2025 |

The Labor Government’s administration of the $19.5 billion Pharmaceutical Benefit Scheme (PBS) has been found to be only “partly effective”. […]

More


This content is copyright protected. Please subscribe to gain access.